Recent Blog Articles
HIV rates rising: Could new forms of PrEP help?
Careful! Scary health news can be harmful to your health
Post-pandemic weight loss: There’s an app for that
Cognitive behavioral therapy for insomnia by telemedicine: Is it as good as in-person treatment?
Prediabetes diagnosis as an older adult: What does it really mean?
Is blood sugar monitoring without diabetes worthwhile?
Large review study finds low risk of erectile dysfunction after prostate biopsy
Does exercise help protect against severe COVID-19?
A new Alzheimer’s drug has been approved. But should you take it?
Need physical therapy? 3 key questions your PT will ask
Lisa Zakhary, MD, PhD
Lisa Zakhary, MD, PhD, serves as Co-Director of Psychopharmacology in the Massachusetts General Hospital (MGH) OCD and Related Disorders Program and Director of Psychopharmacology in the MGH Excoriation Clinic and Research Unit. She received her undergraduate degree from Columbia University and her medical degree from Harvard Medical School. Additionally, she earned a PhD in molecular neurobiology during her medical training. Following medical school, she completed the MGH/McLean Adult Psychiatry Residency and the Boston Psychoanalytic Society & Institute Fellowship before going on to join the MGH faculty.
As Assistant in Psychiatry at MGH, she splits her time between MGH Primary Care Psychiatry and the MGH OCD and Related Disorders Program. Additionally, she is an Instructor in Psychiatry at Harvard Medical School and is part of a group private practice in Arlington, Massachusetts. Dr. Zakhary has a special interest in psychodermatology and as a resident, she co-founded the MGH Comprehensive Skin Management Clinic, a psychiatry/dermatology clinic providing collaborative treatment for patients with compulsive skin picking, trichotillomania, body dysmorphic disorder, and delusions of parasitosis. As staff, she continues to explore ways to optimize psychodermatologic treatment through collaboration, education, and research.